Verona Pharma plc Capital Reinvestment Ratio

Latest as of September 2021: 0.00x

Verona Pharma plc capital reinvestment ratio. Verona Pharma plc (I9SA) has a Capital Reinvestment Ratio of 0.00x as of September 2021, meaning it reinvests 0% of its operating cash flow (€22.82 Million) in capital expenditures (€11.00K). See free cash flow generation of Verona Pharma plc to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

€22.82 Million

EUR

Capital Expenditures

€11.00K

EUR

Data as of

Sep 2021

Most recent filing

Verona Pharma plc Capital Reinvestment Ratio by Year (None–None)

Verona Pharma plc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see I9SA cash flow conversion.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow